| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1993PNAS...90.3655H |
| P356 | DOI | 10.1073/PNAS.90.8.3655 |
| P8608 | Fatcat ID | release_djbdqzcnwzeshhymopoejp2c6m |
| P932 | PMC publication ID | 46360 |
| P698 | PubMed publication ID | 8386379 |
| P5875 | ResearchGate publication ID | 14813686 |
| P2093 | author name string | Sapolsky RM | |
| Ho DY | |||
| Mocarski ES | |||
| P2860 | cites work | A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons | Q46135759 |
| Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences | Q48377640 | ||
| The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation | Q48385238 | ||
| Circadian and light-induced expression of immediate early gene mRNAs in the rat suprachiasmatic nucleus. | Q48428479 | ||
| In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer | Q48544329 | ||
| Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia | Q48945729 | ||
| Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. | Q54738585 | ||
| An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. | Q33899115 | ||
| Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse | Q34308944 | ||
| Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein | Q36425439 | ||
| Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation | Q36538254 | ||
| Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences | Q36656071 | ||
| Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells | Q36781450 | ||
| Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. | Q36781988 | ||
| Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia | Q36851040 | ||
| Transduction of the Chinese hamster ovary aprt gene by herpes simplex virus | Q36895913 | ||
| Expression of a cellular gene cloned in herpes simplex virus: rabbit beta-globin is regulated as an early viral gene in infected fibroblasts | Q36915558 | ||
| A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. | Q37396712 | ||
| Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras | Q37568940 | ||
| Glucocorticoids, hippocampal damage and the glutamatergic synapse | Q37613477 | ||
| Biological differences between ischemia, hypoglycemia, and epilepsy | Q39550601 | ||
| Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization | Q41206360 | ||
| Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins | Q41638024 | ||
| Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants | Q41726334 | ||
| Biosynthetic precursors and in vitro translation products of the glucose transporter of human hepatocarcinoma cells, human fibroblasts, and murine preadipocytes | Q42815259 | ||
| A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons | Q43244050 | ||
| The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector | Q44397432 | ||
| The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes | Q44791050 | ||
| Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes | Q44837556 | ||
| Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse | Q45840767 | ||
| Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants | Q45853839 | ||
| Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: A light and electron microscopic study | Q45880484 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vector-borne disease | Q2083837 |
| physiology | Q521 | ||
| P304 | page(s) | 3655-3659 | |
| P577 | publication date | 1993-04-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene | |
| P478 | volume | 90 |
| Q40838016 | A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors |
| Q44420155 | Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease |
| Q40571051 | Amplicon-based herpes simplex virus vectors. |
| Q36969336 | An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells |
| Q44858702 | An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid |
| Q45862004 | An efficient in vivo recombination cloning procedure for modifying and combining HSV-1 cosmids |
| Q43934769 | Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir |
| Q45869225 | Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease |
| Q43698564 | Calbindin overexpression buffers hippocampal cultures from the energetic impairments caused by glutamate |
| Q33827255 | Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system |
| Q41301290 | Coupled Glucose Transport and Metabolism in Cultured Neuronal Cells: Determination of the Rate-Limiting Step |
| Q45746815 | Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo |
| Q62971299 | Engineering Herpes Simplex |
| Q45764657 | Expression of L1 in primary astrocytes via a defective herpes simplex virus vector promotes neurite outgrowth and neural cell migration |
| Q40571088 | Expression of foreign proteins in a human neuronal system |
| Q40606308 | Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo |
| Q74271971 | Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors |
| Q41175797 | Gene therapy in pediatric oncology |
| Q33651647 | Genetic analysis of the role of protein kinase C signaling pathways in behaviors by direct gene transfer with HSV-1 vectors |
| Q36897379 | HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. |
| Q33995752 | HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications |
| Q37528088 | HSV-1-derived amplicon vectors: recent technological improvements and remaining difficulties--a review |
| Q35870965 | Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. |
| Q45788035 | Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects |
| Q34040013 | Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss |
| Q35863367 | Herpes simplex virus-based vectors |
| Q43764333 | Interactions among ascorbate, dehydroascorbate and glucose transport in cultured hippocampal neurons and glia |
| Q44974102 | Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus |
| Q45880758 | Lipofectin-facilitated transfer of cholecystokinin gene corrects behavioral abnormalities of rats with audiogenic seizures |
| Q39871031 | Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector |
| Q42280576 | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain |
| Q37056974 | Molecular physiology of preconditioning-induced brain tolerance to ischemia |
| Q33913966 | Neighbor effects of neurons bearing protective transgenes |
| Q43678221 | Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events |
| Q35202981 | Neuroprotective potential of a viral vector system induced by a neurological insult |
| Q49108925 | Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke |
| Q36569912 | Regulatable gene expression systems for gene therapy |
| Q36157542 | Regulatable gene expression systems for gene therapy applications: progress and future challenges |
| Q35826119 | Sparing of neuronal function postseizure with gene therapy |
| Q38295529 | The Ras-related GTP-binding protein, Rab1B, regulates early steps in exocytic transport and processing of beta-amyloid precursor protein |
| Q26827823 | The potential roles of 18F-FDG-PET in management of acute stroke patients |
| Q40732042 | Viral gene delivery |
| Q41235446 | Viral vectors for modulating gene expression in neurons |
Search more.